Sales rise 37.35% to Rs 14.01 crore
Net Loss of Genpharmasec reported to Rs 0.27 crore in the quarter ended March 2025 as against net loss of Rs 0.27 crore during the previous quarter ended March 2024. Sales rose 37.35% to Rs 14.01 crore in the quarter ended March 2025 as against Rs 10.20 crore during the previous quarter ended March 2024.For the full year,net profit reported to Rs 1.23 crore in the year ended March 2025 as against net loss of Rs 0.17 crore during the previous year ended March 2024. Sales rose 10.88% to Rs 33.72 crore in the year ended March 2025 as against Rs 30.41 crore during the previous year ended March 2024.
ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales14.0110.20 37 33.7230.41 11 OPM %-7.14-0.10 -0.210.13 - PBDT-0.170.14 PL 2.690.29 828 PBT-0.430.11 PL 1.880.25 652 NP-0.27-0.27 0 1.23-0.17 LP
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
